While Tengion might be making incremental headway in a complex space, investors who buy on the open market are in for a rude awakening -- TNGN is a value trap of epic proportions ... with any company whose stock is mentioned in this …
He initiated a brand new 1,060,070 share position in TNGN during the first quarter. It seems like he increased his bet by 20% as the stock price plunged from $2.55 at the end of March to $1.41 today. Tengion is a micro-cap stock with a …
Tengion, Inc. (Nasdaq: TNGN), announced that its application to transfer the listing of its common stock from The NASDAQ Global Market to The NASDAQ Capital Market has been approved by NASDAQ. This transfer will be effective …
WINSTON-SALEM, N.C., May 30, 2012 /PRNewswire/ -- Tengion, Inc. (NASDAQ: TNGN), a leader in regenerative medicine, today announced that its Board of Directors has approved a reverse split of its common stock at a ratio of 1 …
The East Norriton, Pa., regenerative medicine company has until April 2 to regain compliance. Shares of Tengion’s (NASDAQ:TNGN) common stock must maintain a minimum bid closing price of at least $1 per share for a minimum of …
Underwriters were led by Piper Jaffray and Leerink Swann. Metals USA is trading on the New York Stock Exchange under the symbol "MUSA." Tengion is trading on the Nasdaq under the symbol "TNGN."
Regenerative medicine company Tengion (NASDAQ:TNGN ... company for a stock-for-stock merger had terminated. At the time, the company said it had enough money to last until April of that year. The private placement that included …
BOSTON (MarketWatch) -- Shares of Tengion Inc. tngn plunged almost 50% midday Wednesday after the ... Tengion said that it had been in discussions with a publicly-traded company over a possible stock-for-stock merger. "As a result of …
Biotech firm Tengion (NASDAQ: TNGN) went public on April 9th ... At the time of writing, Tengion stock has been hovering right around its IPO price of $5. Where's the rush to invest in growing organs in a lab? Tengion’s IPO was handled by …